Orally administrable modified-release pharmaceutical dosage form
The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Stroyer, Anke Rubenbauer, Philipp Serno, Peter Küsel, Julia Schirmer, Heiko Lovis, Kai Jacobs, Tia Olenik, Britta Bierer, Donald Lobback, Carmen Grossbach, Danja |
| description | The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiac, renal and pulmonary disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11344519B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11344519B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11344519B23</originalsourceid><addsrcrecordid>eNrjZHDwL0rMyalUSEzJzczLLC4pSkzKSVXIzU_JTMtMTdEtSs1JTSxOVSjISCzKTUxOLS3JTE7MUUjJL05MT1VIyy_K5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFQE15qSXxocGGhsYmJqaGlk5GxsSoAQAUYDH-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Orally administrable modified-release pharmaceutical dosage form</title><source>esp@cenet</source><creator>Stroyer, Anke ; Rubenbauer, Philipp ; Serno, Peter ; Küsel, Julia ; Schirmer, Heiko ; Lovis, Kai ; Jacobs, Tia ; Olenik, Britta ; Bierer, Donald ; Lobback, Carmen ; Grossbach, Danja</creator><creatorcontrib>Stroyer, Anke ; Rubenbauer, Philipp ; Serno, Peter ; Küsel, Julia ; Schirmer, Heiko ; Lovis, Kai ; Jacobs, Tia ; Olenik, Britta ; Bierer, Donald ; Lobback, Carmen ; Grossbach, Danja</creatorcontrib><description>The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiac, renal and pulmonary disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic disorders.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220531&DB=EPODOC&CC=US&NR=11344519B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220531&DB=EPODOC&CC=US&NR=11344519B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Stroyer, Anke</creatorcontrib><creatorcontrib>Rubenbauer, Philipp</creatorcontrib><creatorcontrib>Serno, Peter</creatorcontrib><creatorcontrib>Küsel, Julia</creatorcontrib><creatorcontrib>Schirmer, Heiko</creatorcontrib><creatorcontrib>Lovis, Kai</creatorcontrib><creatorcontrib>Jacobs, Tia</creatorcontrib><creatorcontrib>Olenik, Britta</creatorcontrib><creatorcontrib>Bierer, Donald</creatorcontrib><creatorcontrib>Lobback, Carmen</creatorcontrib><creatorcontrib>Grossbach, Danja</creatorcontrib><title>Orally administrable modified-release pharmaceutical dosage form</title><description>The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiac, renal and pulmonary disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic disorders.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDwL0rMyalUSEzJzczLLC4pSkzKSVXIzU_JTMtMTdEtSs1JTSxOVSjISCzKTUxOLS3JTE7MUUjJL05MT1VIyy_K5WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFQE15qSXxocGGhsYmJqaGlk5GxsSoAQAUYDH-</recordid><startdate>20220531</startdate><enddate>20220531</enddate><creator>Stroyer, Anke</creator><creator>Rubenbauer, Philipp</creator><creator>Serno, Peter</creator><creator>Küsel, Julia</creator><creator>Schirmer, Heiko</creator><creator>Lovis, Kai</creator><creator>Jacobs, Tia</creator><creator>Olenik, Britta</creator><creator>Bierer, Donald</creator><creator>Lobback, Carmen</creator><creator>Grossbach, Danja</creator><scope>EVB</scope></search><sort><creationdate>20220531</creationdate><title>Orally administrable modified-release pharmaceutical dosage form</title><author>Stroyer, Anke ; Rubenbauer, Philipp ; Serno, Peter ; Küsel, Julia ; Schirmer, Heiko ; Lovis, Kai ; Jacobs, Tia ; Olenik, Britta ; Bierer, Donald ; Lobback, Carmen ; Grossbach, Danja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11344519B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Stroyer, Anke</creatorcontrib><creatorcontrib>Rubenbauer, Philipp</creatorcontrib><creatorcontrib>Serno, Peter</creatorcontrib><creatorcontrib>Küsel, Julia</creatorcontrib><creatorcontrib>Schirmer, Heiko</creatorcontrib><creatorcontrib>Lovis, Kai</creatorcontrib><creatorcontrib>Jacobs, Tia</creatorcontrib><creatorcontrib>Olenik, Britta</creatorcontrib><creatorcontrib>Bierer, Donald</creatorcontrib><creatorcontrib>Lobback, Carmen</creatorcontrib><creatorcontrib>Grossbach, Danja</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Stroyer, Anke</au><au>Rubenbauer, Philipp</au><au>Serno, Peter</au><au>Küsel, Julia</au><au>Schirmer, Heiko</au><au>Lovis, Kai</au><au>Jacobs, Tia</au><au>Olenik, Britta</au><au>Bierer, Donald</au><au>Lobback, Carmen</au><au>Grossbach, Danja</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Orally administrable modified-release pharmaceutical dosage form</title><date>2022-05-31</date><risdate>2022</risdate><abstract>The present invention relates to orally administrable modified-release pharmaceutical dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate and to processes for preparing the dosage forms and to their use for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiac, renal and pulmonary disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11344519B2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Orally administrable modified-release pharmaceutical dosage form |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A03%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Stroyer,%20Anke&rft.date=2022-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11344519B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |